These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Role and therapeutic use of deferoxamine in iron overload due to thalassemia (author's transl)].
    Author: Lévy G, Bachelot C, Joannard A, Bost M.
    Journal: Arch Fr Pediatr; 1980 May; 37(5):299-303. PubMed ID: 7469704.
    Abstract:
    Eight children aged between 4 and 16 years with thalassemia major were treated for 30 months with repeated transfusions and a chelating agent. Deferoxamine was given intravenously for 12 months and subcutaneously in the next 18 months. The results of urine iron concentrations, the practical difficulties of both routes of administration and the clinical results are presented. The therapeutic regime proposed is capable or reducing the iron overload.
    [Abstract] [Full Text] [Related] [New Search]